KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $24.4 million.

  • CareDx's Cost of Revenue rose 2346.73% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.8 million, marking a year-over-year increase of 1509.31%. This contributed to the annual value of $81.7 million for FY2024, which is 193.92% down from last year.
  • Latest data reveals that CareDx reported Cost of Revenue of $24.4 million as of Q3 2025, which was up 2346.73% from $24.3 million recorded in Q2 2025.
  • CareDx's Cost of Revenue's 5-year high stood at $27.0 million during Q2 2022, with a 5-year trough of $15.5 million in Q1 2021.
  • Over the past 5 years, CareDx's median Cost of Revenue value was $21.4 million (recorded in 2021), while the average stood at $21.6 million.
  • In the last 5 years, CareDx's Cost of Revenue soared by 6152.13% in 2021 and then tumbled by 1974.03% in 2023.
  • Over the past 5 years, CareDx's Cost of Revenue (Quarter) stood at $20.8 million in 2021, then rose by 13.66% to $23.7 million in 2022, then fell by 15.5% to $20.0 million in 2023, then rose by 5.43% to $21.1 million in 2024, then rose by 15.96% to $24.4 million in 2025.
  • Its Cost of Revenue stands at $24.4 million for Q3 2025, versus $24.3 million for Q2 2025 and $23.0 million for Q1 2025.